robust q2 for indian pharma | nithya balasubramanian of sanford bernstein to et now
Published 3 years ago • 1.1K plays • Length 8:49Download video MP4
Download video MP3
Similar videos
-
12:30
is pharma ripe for re-rating? | nithya balasubramanian of sanford bernstein to et now
-
9:35
where is value in pharma pack? | nithya balasubramanian, sanford bernstein
-
13:34
pain in pharma pack? | nithya balasubramanian, sanford bernstein & a vaidheesh, former md,gsk pharma
-
6:59
cipla vs sun pharma - is pharma ready for a turnaround? | nithya balasubramanian, sanford bernstein
-
12:02
will pharma stocks rally continue? nithya balasubramanian of bernstein | business news
-
10:00
how's the generics market shaping up in pharma sector? | nithya balasubramanian | et now
-
11:46
sanford bernstein's nithya balasubramanian shares her views on biocon, gland pharma | cnbc-tv18
-
11:32
what does 2022 hold for pharma companies? | a vaidheesh & nithya balasubramanian
-
15:32
investors concerned about us generic pricing pressure | nithya balasubramanian, sanford bernstein
-
7:57
sanford bernstein's nithya balasubramanian on q4 results of pharma cos & china opportunity
-
14:26
nithya balasubramanian explains why pharma stocks are buzzing
-
6:49
what is in the covid portfolio of top pharma companies? | nithya balasubramanian to et now
-
10:05
sanford bernstein's nithya balasubramanian's take on pharma universe | bazaar morning call
-
10:11
sanford bernstein's nithya balasubramanian's take on pharma stocks amid covid-19 concerns
-
13:00
why the buzz in pharma stocks | nithya balasubramanian & kewal handa discuss
-
13:39
robust q2 for five-star business|disbursement, collection intact? | srikanth gopalakrishnan explains